Skip to main content
. Author manuscript; available in PMC: 2014 Jul 28.
Published in final edited form as: Circ J. 2013 Jun 25;77(10):2558–2566. doi: 10.1253/circj.cj-13-0305

Figure 6.

Figure 6

Effect of the GBR antagonist, CGP35348, and the agonist, baclofen, on MAP and HR in SHR or WKY rats. A and B: Time course data showing the MAP (A) and HR (B) changes evoked by baclofen (50 pmol in 50 nl) microinjected into the NTS of SHR (filled dots) and WKY rats (open dots). Values are means±SE (n=6 rats in each group). *P<0.05 or **P<0.01 as compared with respective basal condition. C and D: time course data showing the MAP (C) and HR (D) changes evoked by CGP35348 (100 pmol in 50 nl) microinjected into the NTS of SHR (filled dots) and WKY rats (open dots). Values are means±SE (n=5 or 6 rats in each group). *P<0.05 or **P<0.01 as compared with respective basal condition. E and F: Bar graphs showing MAP (E) and HR (F) changes evoked by microinjection of baclofen or CGP35348 into the NTS of SHR and WKY rats. Values are means± SE (n=6 or 5 rats in each group). *p< 0.05 vs. WKY in each group of rats.